Cohen, S J <br/><br/>
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Jul 2009 
 - 1223-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdn786  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Bevacizumab<br/>Camptothecin--analogs & derivatives<br/>Colorectal Neoplasms--drug therapy<br/>Disease Progression<br/>Disease-Free Survival<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Irinotecan<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis--pathology<br/>Neoplastic Cells, Circulating--pathology<br/>Organoplatinum Compounds--therapeutic use<br/>Oxaliplatin<br/>Predictive Value of Tests<br/>Prognosis<br/>Survival Rate<br/>Time Factors<br/>Treatment Outcome